Women’s Health

Gestational diabetes is usually treated as a single diagnosis, but growing evidence suggests the biology behind it can vary considerably from one patient to another. Researchers studying gestational diabetes phenotypes have identified metabolic patterns involving differences in insulin resistance, insulin secretion, or both. These findings raise an important question: Could …

Diabetes prevention remains important long after a pregnancy affected by gestational diabetes. For people who have had gestational diabetes, the years after delivery are an important window for lowering the risk of Type 2 diabetes. Yet healthy choices do not happen in a vacuum. Where someone lives may affect whether …

Many women with diabetes notice that blood sugar levels become harder to control during certain weeks of the month. Despite eating the same meals, taking the same insulin doses, and maintaining consistent activity levels, glucose readings may suddenly climb. This recurring pattern is often linked to luteal phase insulin resistance, …

Postpartum screening after gestational diabetes is one of the most important yet overlooked steps in preventing future type 2 diabetes. Although blood glucose levels often return to normal after delivery, the long-term metabolic risk does not disappear. In fact, up to half of individuals diagnosed with gestational diabetes mellitus (GDM) …

Sexual health remains one of the most overlooked aspects of diabetes management, despite its significant impact on quality of life. While clinicians routinely discuss glycemic control, cardiovascular risk, and medication adherence, conversations about sexual function are often avoided by both patients and healthcare providers. Yet sexual health concerns related to …

Urinary incontinence is one of the most common yet least discussed complications of diabetes. In fact, diabetes urinary incontinence affects people with diabetes at significantly higher rates than the general population. While healthcare professionals routinely monitor patients for retinopathy, nephropathy, and cardiovascular disease, bladder dysfunction often remains overlooked. However, research …

The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …

GLP-1 receptor agonists are transforming diabetes and obesity care. However, as more women of reproductive age use medications like semaglutide, liraglutide, and tirzepatide, questions about how GLP-1 therapies affect fertility and pregnancy are becoming increasingly common. Can patients conceive safely while taking these agents? Do they improve ovulation in women …

Menopause marks a major transition in a woman’s life, defined not only by the end of menstrual cycles but also by profound hormonal and metabolic changes. One often under‑recognized shift is the acceleration of cardiometabolic risk. Women in midlife frequently experience increased central adiposity, changes in glucose regulation, rising blood …

Could a diabetes medication help women with PCOS regain control of their cycles and metabolism? GLP‑1 receptor agonists, best known for treating type 2 diabetes and obesity, are showing promise for women with polycystic ovary syndrome (PCOS). These medications may support weight loss, improve insulin resistance, and even lead to …